ProBioGen and Thermo Fisher Scientific Gibco Freedom ExpiCHO-S Kit

Wednesday, 09 November, 2022 | Supplied by: Thermo Fisher Scientific


ProBioGen and Thermo Fisher Scientific have teamed up to develop the Gibco Freedom ExpiCHO-S Kit. The kit allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.

The kit uses Thermo Fisher’s ExpiCHO-S cell line and a powerful media platform specifically developed for it. The kit is based on a novel set of ProBioGen vectors equipped with strong promoters, selection markers and protective elements providing expression stability. Together with a simple workflow optimised by ProBioGen, the kit provides short development time, reproducibly high titres (3–5 g/L) and high expression stability.

Generating a stable and high-performing cell line is the starting point for successful pharmaceutical development. With this in mind, the kit allows a seamless transition from transient to stable production reproducing previously found product modifications. Moreover, the specific ProBioGen vector composition offers flexibility not only for antibodies but in particular for a variety of novel product formats.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...

Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration

The antibodies are specific to CTC surface markers to enable the sensitive and specific...

Microbiologics UV-BioTAG QC microorganisms for quality control testing

UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd